Status: current, Defined. Date: 28-Feb 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3110571000168112 | Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 0.5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3110581000168110 | Boostrix injection, 0.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Boostrix injection, 0.5 mL vial | has TPUU | True | Boostrix injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL vial (trade product pack) | has TPUU | True | Boostrix injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Boostrix injection, 10 x 0.5 mL vials | has TPUU | True | Boostrix injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Boostrix injection, 10 x 0.5 mL vials | has TPUU | True | Boostrix injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set